Stember Tang

Stember Tang is an experienced clinical trial manager with a strong background in clinical research and development. Currently serving as a Senior Clinical Trial Manager at Aimmune Therapeutics since October 2018, Stember has previously held key roles at leading companies such as Genentech, FibroGen, Abbott Vascular, Tethys Bioscience, St. Jude Medical, and Mannkind Corp. Notable positions include Country Study Specialist/Consultant at Genentech and Senior Clinical Research Associate at both FibroGen and Abbott Vascular. Stember Tang holds a Master of Science in Biomedical Engineering from UCLA and a Bachelor's degree in Neuroscience from the University of California, Riverside.